Begin main content

fluticasone propionate

Last Updated: October 26, 2017
Result type: Reports
Project Number: SR0539-000
Product Line: Common Drug Review

Generic Name: fluticasone propionate

Brand Name: Aermony RespiClick

Manufacturer: TEVA Canada Innovation

Indications: Asthma

Submission Type: New

Project Status: Active

Biosimilar: No

Fee Schedule1: Pending

Key Milestones2

Call for patient input posted3September 05, 2017
Patient group input closed3October 25, 2017
Clarification:

- Patient input submission received

Patient input summary sent for review to patient input groups-
Patient group comments on input summary closed-
Submission receivedOctober 04, 2017
Submission accepted for reviewOctober 19, 2017
Review initiated-
Draft CDR review report(s) sent to applicant-
Comments from applicant on draft CDR review report(s) received-
Redaction requests from applicant on draft CDR review report(s) received-
CDR review team's comments on draft CDR review report(s) sent to applicant-
Canadian Drug Expert Committee (CDEC) meeting-
CDEC recommendation & redacted CDR review report(s) sent to applicant and drug plans-

Tags

asthma, respiratory